These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20140192)

  • 41. Early Vertebrate Evolution of the Host Restriction Factor Tetherin.
    Heusinger E; Kluge SF; Kirchhoff F; Sauter D
    J Virol; 2015 Dec; 89(23):12154-65. PubMed ID: 26401043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
    Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
    J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
    Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
    mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The great escape: viral strategies to counter BST-2/tetherin.
    Douglas JL; Gustin JK; Viswanathan K; Mansouri M; Moses AV; Früh K
    PLoS Pathog; 2010 May; 6(5):e1000913. PubMed ID: 20485522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dimerization of the transmembrane domain of human tetherin in membrane mimetic environments.
    Cole G; Simonetti K; Ademi I; Sharpe S
    Biochemistry; 2012 Jun; 51(25):5033-40. PubMed ID: 22667354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rab7A is required for efficient production of infectious HIV-1.
    Caillet M; Janvier K; Pelchen-Matthews A; Delcroix-Genête D; Camus G; Marsh M; Berlioz-Torrent C
    PLoS Pathog; 2011 Nov; 7(11):e1002347. PubMed ID: 22072966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BST-2 diminishes HIV-1 infectivity.
    Zhang J; Liang C
    J Virol; 2010 Dec; 84(23):12336-43. PubMed ID: 20861258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway.
    Madjo U; Leymarie O; Frémont S; Kuster A; Nehlich M; Gallois-Montbrun S; Janvier K; Berlioz-Torrent C
    Cell Rep; 2016 Nov; 17(9):2221-2233. PubMed ID: 27880899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.
    Blondeau C; Pelchen-Matthews A; Mlcochova P; Marsh M; Milne RS; Towers GJ
    J Virol; 2013 Dec; 87(24):13124-33. PubMed ID: 24067975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin.
    Lv M; Wang J; Zhu Y; Wang X; Zuo T; Liu D; Zhang J; Wu J; Zhang H; Kong W; Yu X
    FEBS Lett; 2013 Jan; 587(1):37-43. PubMed ID: 23201263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural basis of tetherin function.
    Weissenhorn W; Miguet N; Aschman N; Renesto P; Usami Y; Gottlinger HG
    Curr HIV Res; 2012 Jun; 10(4):298-306. PubMed ID: 22524178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tethered virions are intermediates in the assembly and release of HIV-1 particles.
    Karetnikov A; Suomalainen M
    Virology; 2010 Nov; 407(2):289-95. PubMed ID: 20850859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of calcium-modulating cyclophilin ligand on human immunodeficiency virus type 1 particle release and cell surface expression of tetherin.
    Bego MG; Dubé M; Mercier J; Cohen EA
    J Virol; 2009 Dec; 83(24):13032-6. PubMed ID: 19793820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells.
    Bego MG; Côté É; Aschman N; Mercier J; Weissenhorn W; Cohen ÉA
    PLoS Pathog; 2015 Jul; 11(7):e1005024. PubMed ID: 26172439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of Lassa and Marburg virus production by tetherin.
    Sakuma T; Noda T; Urata S; Kawaoka Y; Yasuda J
    J Virol; 2009 Mar; 83(5):2382-5. PubMed ID: 19091864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tetherin can restrict cell-free and cell-cell transmission of HIV from primary macrophages to T cells.
    Giese S; Marsh M
    PLoS Pathog; 2014 Jul; 10(7):e1004189. PubMed ID: 24991932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Nef Protein of the Macrophage Tropic HIV-1 Strain AD8 Counteracts Human BST-2/Tetherin.
    Giese S; Lawrence SP; Mazzon M; Nijmeijer BM; Marsh M
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32325729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tetherin Inhibits Cell-Free Virus Dissemination and Retards Murine Leukemia Virus Pathogenesis.
    Liberatore RA; Mastrocola EJ; Powell C; Bieniasz PD
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Release of filamentous and spherical influenza A virus is not restricted by tetherin.
    Bruce EA; Abbink TE; Wise HM; Rollason R; Galao RP; Banting G; Neil SJ; Digard P
    J Gen Virol; 2012 May; 93(Pt 5):963-969. PubMed ID: 22258861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The viral protein U (Vpu)-interacting host protein ATP6V0C down-regulates cell-surface expression of tetherin and thereby contributes to HIV-1 release.
    Waheed AA; Swiderski M; Khan A; Gitzen A; Majadly A; Freed EO
    J Biol Chem; 2020 May; 295(21):7327-7340. PubMed ID: 32291285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.